Sunrise Oncology Partners
233 Spring Street
New York, NY 10013
P: (212) 123­1223
F: (212) 123­1224
Patient Nam e:  Mott, Elizabeth 
Patient Number: 12345678Date:  08/28/2018
Date Of Birth:   08/29/1960
Date Type Details Outcome Comment
5/1/2018 Other Therapies Synthroid 175 mcg tablet Active
5/1/2018 Other Therapies Zoloft 50 mg tablet Active
Allergies
No known allergies have been entered for this patient.
Medical and Surgical History
Hypothyroidism. Mild anxiety.
Date Type ICD­9 ICD­10 Problem Comment Status
Date Type Details Outcome Comment
9/18/2018 Surgery Tonsillectomy 1960s
Social History
Patient is married.  No history of tobacco use.  Mrs. Mott reports the following support system: lives with family. Her diet consists of regular 
meals. She indicates her daily activity level as: daily activities.
Alco
hol
 Use Yes, Weekly.
Family Hi
story
Reviewed and unchanged.
Gyn History
Menarche at the age of 12. LMP more than 10 years ago.
Review  O
f Systems
Constitu ti
onal Symptoms: Patient reports:  mild fatigue,  no weakness,  no weight loss,  no fevers,  no chills, no diaphoresis,  no night 
sweat s 
, no hot flashes.  exertional dyspnea, no cough
Eyes:
 Patient offers no eye complaints. 
Gastrointestinal : Patient offers no gastrointestinal complaints.  no nausea,  no vomiting,   no dysphagia,  no abdominal pain,   no diarrhea,  no 
constipation
Musculoskeletal: bone pain,  no back pain,  no art hralgia 
Integumentary: Patient reports: no rash, no pruritis, no skin lesions, no dry skin
Page 1 of 2  
FOLLOW UP VISIT
Chief Complaint
Mrs. Mott is a 57 year old woman who was diagnosed with breast cancer  in April 2018. S he was found to have extensive 
bone metastases , adenopathy and hepatic lesions. Tumor was biopsied showing ER positive, P R positive, Her2 am plified 
breast cancer. Started paclitaxel, trastuzumab and pertuzumab 5/8/18. Added zolendronic acid. Completed four cycles  of 
TH and pertuzumab. Here for cycle five. While she reports increased anxiety since her last visit, Elizabeth is excited for her 
birthday tomorrow. Husband and sister are present for today's visit.
Ongoing Treatment EventsNeurological: Patient reports: no headache, no peripheral neuropathy, no focal weakness, no tremor, no altered consciousness, n
oseizures, no speech impairment, no dizziness.  no paralysis,  nervousness,
Vital Signs
Vitals on  8/28/18  11:03:00 AM: Height=66in, Weight=155lb, Pulse=74, SystolicBP=122, DiastolicBP=68  
Ph
ysical 
General:  Patient appears:  well developed and well nourished,  No  alopecia noted.  
Eyes: No scleral icterus, and/or pallor. Conjunctiva clear. EOMs intact. Pupils equal and reactive to light. 
Cardi
ovascular:  Heart with regular rate and rhythm. Normal S1 and S2. S3, S4 No gallop. No rubs or clicks. No bruits. Pedal pulses  
present
. 
Chest: Clear 
no rales/rhonchi. No dullness to percussion. No wheezing. Chest wall expansion normal. No chest wall tenderness. No  
stridor. 
Abd
omen: Soft. Non­tender. Non­distended. No palpable masses. No ascites. No hepatosplenomegaly. Bowel sounds present in all 
quadrants.
 No hernia. 
Hematologic/
Lymp
hatic: No cervical lymphadenopathy. No supraclavicular lymphadenopathy. No axillary lymphadenopathy. No inguinal  
lymphadenopathy. No petechiae. No ecchymosis. 
Ski
n: No rashes. No lesions.  Extremities appear normal. No evidence of cyanosis.  No edema.  No clubbing present. 
Neurologic:  Alert and oriented.  Normal speech.  Cranial nerves in tact.  
Genitourinary:  Examination deferred.  
Rectal
: Examination deferred.  
G
ynecological:  Examination deferred.
Laboratory Results
Lab results on 8/28/2018: Sodium=135 mmol/L, Potassium=4.2 mmol/L, CO2=31 mmol/L, Chloride=99 mmol/L, Glucose=84 mg/dL, 
Calcium=9.0 mg/dL, BUN=14 mg/dL, Creat=1.1 mg/dL, Alk Phos=45 U/L, ALT=21 U/L, AST=23 U/L, Total Bili=0.9 mg/dL, Albumin=3.7g 
dL, Total Protein=7.5 g/dL. WBC=4.1 x10E3/uL, RBC=4.63 x10E6/uL, HGB=9.9 g/dL, HCT=31.4%,
 MCV=68 fL, MCH=21.4 pg, 
MCHC=31.5 g/dL, RDW=16.1 %, Plat=179 x10E3/uL, ANC=2.8 x10E3/uL, Lymph#=1.0 x10E3/uL, MONO#=0.2  x10E3/uL, BASO#=0.1 
x10E3/uL, EOS#=0.1 x10E3/uL, MONO%=5 %, BASO%=1 %, EOS%=1 %, Neut%=68 %
Imag
ing Results
Radiology results were reviewed and discussed with the patient, including 4/2018- MRI Brain no metastasis deep white matter changes 
suggestive of inflammatory process. PET/CT
 - left breast mass; diffuse bone metastases; liver lesions suspicious for metastatic breast 
cancer.
Primary Dx 
198.5 - Secondary malignant neoplasm of bone and bone marrow, Diagnosed Apr
 2018
174.9 - Malignant neoplasm of breast (female), unspecified site, Diagnosed Apr 2018
Assessment
St
age 4  ER HER2 positive breast cancer with bone and liver metastases. Patient had a negative brain MRI.  Testing of tumor 
demonstrates ER+ PR+. HER2neu equivocal on IHC. FISH positive. Completed four cycles of TH plus  pertuzumab with response. CT 
CAP last month showed interval decrease in size of liver lesions, stable bone metastases. Next imaging in 6 to 8 weeks. Tolerating 
treatment well overall, mild fatigue. Proceed with C5.
Recommen
dation/Plan
Time spent with patient was  25 minutes. Over half the time was spent counseling and coordinating care, which included the  
fol
lowing:
Arranged patient treatment education.
Reviewed 
with patient  treatment side effects.
Supportive measures reviewed.
Cont Taxol, Herceptin and Perjeta.
All 
questions answered.
Page 2 of 2  Electronically signed:DATE Aug 28, 2018  
TIME 11:45AM  
Shannon Wu, M.D.
